AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Lifecare ASA

AGM Information Apr 30, 2024

3654_rns_2024-04-30_690e2832-8704-414f-9c2a-1beb1a8e69bd.html

AGM Information

Open in Viewer

Opens in native device viewer

Minutes from Annual General Meeting

Minutes from Annual General Meeting

The Annual General Meeting of Lifecare AS was convened as a hybrid meeting on

30 April 2024.

Trine Teigland (Board member) and Lutz Heinemann (Board member) were

re-elected and Tone Kvåle (Board member) was elected as new member of the BoD

as proposed by the Nomination Committee. No alternative candidates were

proposed.

All proposals on the agenda were adopted, cf. the notification of the Annual

General Meeting that was published on Oslo Stock Exchange on 16. April 2024.

The complete minutes of the Annual General Meeting are attached and will be

available on https://lifecare.no/investor-relations/

About us

Lifecare AS is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

[email protected], +47 41 61 42 52

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2024-04-30 15:40 CEST.

Talk to a Data Expert

Have a question? We'll get back to you promptly.